Ketamine for Neuropathic Pain Treatment
Ketamine is used to treat a variety of chronic pain syndromes, especially those with a neuropathic component. Neuropathic pain is a shooting, burning pain that is usually caused by nerve damage or a malfunctioning nervous system. Antidepressant and anticonvulsive drugs are usually prescribed for the treatment of neuropathic pain and often do not provide a great deal of relief. Progressive symptoms from neuropathic pain also may lead to disabilities to comorbid mood disorders.
Ketamine has been an effective treatment for pain since the early 1960s and is widely used in hospitals and ambulatory surgery centers for the treatment of pain during surgical procedures. Ketamine has the unique ability to not only block NMDA receptors, but it alters the way brain cells communicate by creating new pathways. This process of synaptogenesis or synaptic plasticity is believed to result in changes in the patient’s mood, anxiety, and response to pain.
Ketamine can help with neuropathic pain caused by:
- Alcoholism
- Amputation – including phantom pain
- Chemotherapy
- Complex regional pain syndrome (CRPS)
- Diabetes
- Facial nerve problems
- Fibromyalgia
- HIV infection or AIDS
- Multiple myeloma
- Multiple sclerosis
- Nerve or spinal cord compression (herniated discs, arthritis)
- Spine surgery
- Thyroid problems
A single ketamine infusion may provide immediate relief from neuropathic pain that generally lasts a few hours to several days depending on the severity of the condition. Continuous ketamine infusion is recommended for longer onset relief. Ask our knowledgeable staff how we can assist in your journey to a better quality of life without pain.
Can Ketamine for Nueropathic Pain Help You?
Request Your Free Consultation Now
If you or a loved one is struggling with neuropathic pain, and other treatment methods have failed to provide relief, then ketamine may be a viable treatment option for you. Contact us today to learn more about our ketamine treatments for neuropathic pain in London, UK.